Sumant Ramachandra's Net Worth
$36.1 Million
Who is Sumant Ramachandra?
Sumant Ramachandra has an estimated net worth of $36.1 Million. This is based on reported shares across multiple companies, which include SYNTA PHARMACEUTICALS CORP, and HOSPIRA INC.
SEC CIK
Sumant Ramachandra's CIK is 0001439368
Past Insider Trading and Trends
2010 was Sumant Ramachandra's most active year for acquiring shares with 16 total transactions. Sumant Ramachandra's most active month to acquire stocks was the month of August. 2015 was Sumant Ramachandra's most active year for disposing of shares, totalling 7 transactions. Sumant Ramachandra's most active month to dispose stocks was the month of February. 2015 saw Sumant Ramachandra paying a total of $7,734,077.46 for 190,743 shares, this is the most they've acquired in one year. In 2015 Sumant Ramachandra cashed out on 367,715 shares for a total of $21,141,922.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SYNTA PHARMACEUTICALS CORP (MDGL) Snapshot price: $243.89
President, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 75K |
—
| $7.50 | 75K |
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOSPIRA INC No price found
SVP & Chief Scientifc Ofcr
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -89.42K |
$65.03 | -$16,051,772.54 |
0
|
Aug 14 - Sep 3
| |||
Form 4
| -2.37% | -2.16K |
$88.81 | -$191,918.41 | 89.15K |
Jun 26
| |||
Form 4
| -2.51% | -2.35K |
$87.54 | -$205,543.92 | 91.31K |
Feb 26
| |||
Form 4
| +58.26% | 34.48K |
$87.50 | $3,017,000.00 | 93.66K |
Feb 25
| |||
Form 4
| -3.15% | -1.93K |
$50.88 | -$97,944.00 | 59.18K |
Jun 27
| |||
Form 4
| +58.85% | 22.64K |
—
|
—
| 61.11K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
| +86.52% | 17.84K |
—
|
—
| 38.47K |
Jun 28
| |||
Form 4
|
—
|
0
|
$35.53 | -$7,850.10 | 20.62K |
Scheduled
|
Jun 7
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +134.84% | 11.84K |
—
|
—
| 20.62K |
Mar 1
| |||
Form 4
| -41.45% | -6.22K |
$37.00 | -$230,066.00 | 8.78K |
Sep 30
| |||
Form 4
| -57.18% | -20.03K |
$37.89 | -$3,575,471.97 | 15K |
Scheduled
|
Mar 8
| ||
Form 4
| +133.53% | 20.03K |
$52.46 | -$523,078.66 | 35.03K |
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyell Immunopharma, Inc. (LYEL) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||